Metabolic syndrome affects breast-cancer risk in postmenopausal women: National Cancer Institute of Naples experience

Immacolata Capasso, Emanuela Esposito, Francesca Pentimalli, Anna Crispo, Maurizio Montella, Maria Grimaldi, Mariarosaria De Marco, Ernestina Cavalcanti, Massimiliano D'Aiuto, Alfredo Fucito, Giuseppe Frasci, Nicola Maurea, Giuseppe Esposito, Tonino Pedicini, Aldo Vecchione, Giuseppe D'Aiuto, Antonio Giordano

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Postmenopausal women show the highest incidence of breast cancer in the female population and are often affected by metabolic syndrome. Metabolic syndrome (MS)-characterized by central adiposity, insulin resistance, low serum high-density lipoprotein cholesterol (HDL-C), high serum triglyceride and high blood pressure-seems to be strictly correlated to breast carcinogenesis. We enrolled 777 healthy women and women with breast cancer in our nested casecontrol study to evaluate the association between MS and breast cancer, analyzing anthropometric parameters (weight, height, BMI, waist and hip circumference), blood pressure, serum HDL-C, triglyceride, fasting plasma glucose, insulin, testosterone and uric acid levels and administering a questionnaire about physical activity, food intake, tobacco use, alcohol abuse, personal and familial history of disease. We found an higher prevalence of metabolic syndrome (30%) in postmenopausal breast cancer patients compared to healthy women (19%). None of the individual MS features was strong enough to be considered responsible for breast carcinogenesis alone. However, of the 63 postmenopausal breast cancer cases associated to MS, 30% presented three or more MS features, suggesting that the activation of multiple molecular pathways underlying MS might contribute to tumorigenesis. Our data support the hypothesis that MS may be an indicator of breast cancer risk in postmenopausal women. The unsettlement of the hormonal arrangement in postmenopausal, along with an increase in visceral adiposity, probably favour the hormone-dependent cell proliferation, which drives tumorigenesis. Adjustments in lifestyle with physical activity intensification and healthy diet could represent modifiable factors for the primary prevention of sporadic breast cancer.

Original languageEnglish
Pages (from-to)1240-1243
Number of pages4
JournalCancer Biology and Therapy
Volume10
Issue number12
DOIs
Publication statusPublished - Dec 15 2010

Fingerprint

National Cancer Institute (U.S.)
Breast Neoplasms
Carcinogenesis
Adiposity
HDL Cholesterol
Triglycerides
Breast
Serum
Exercise
Social Adjustment
Tobacco Use
Waist Circumference
Primary Prevention
Metabolic Networks and Pathways
Uric Acid
Alcoholism
Insulin Resistance
Testosterone
Life Style
Hip

Keywords

  • Body mass index
  • Breast cancer
  • High-density lipoprotein cholesterol (HDL-C)
  • Hyperandrogenic status
  • Hyperinsulinemia
  • Insulin resistance
  • Insulin-like growth factor 1 (IGF-1)
  • Metabolic syndrome
  • Postmenopausal
  • Weight gain

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

Metabolic syndrome affects breast-cancer risk in postmenopausal women : National Cancer Institute of Naples experience. / Capasso, Immacolata; Esposito, Emanuela; Pentimalli, Francesca; Crispo, Anna; Montella, Maurizio; Grimaldi, Maria; De Marco, Mariarosaria; Cavalcanti, Ernestina; D'Aiuto, Massimiliano; Fucito, Alfredo; Frasci, Giuseppe; Maurea, Nicola; Esposito, Giuseppe; Pedicini, Tonino; Vecchione, Aldo; D'Aiuto, Giuseppe; Giordano, Antonio.

In: Cancer Biology and Therapy, Vol. 10, No. 12, 15.12.2010, p. 1240-1243.

Research output: Contribution to journalArticle

Capasso, I, Esposito, E, Pentimalli, F, Crispo, A, Montella, M, Grimaldi, M, De Marco, M, Cavalcanti, E, D'Aiuto, M, Fucito, A, Frasci, G, Maurea, N, Esposito, G, Pedicini, T, Vecchione, A, D'Aiuto, G & Giordano, A 2010, 'Metabolic syndrome affects breast-cancer risk in postmenopausal women: National Cancer Institute of Naples experience', Cancer Biology and Therapy, vol. 10, no. 12, pp. 1240-1243. https://doi.org/10.4161/cbt.10.12.13473
Capasso, Immacolata ; Esposito, Emanuela ; Pentimalli, Francesca ; Crispo, Anna ; Montella, Maurizio ; Grimaldi, Maria ; De Marco, Mariarosaria ; Cavalcanti, Ernestina ; D'Aiuto, Massimiliano ; Fucito, Alfredo ; Frasci, Giuseppe ; Maurea, Nicola ; Esposito, Giuseppe ; Pedicini, Tonino ; Vecchione, Aldo ; D'Aiuto, Giuseppe ; Giordano, Antonio. / Metabolic syndrome affects breast-cancer risk in postmenopausal women : National Cancer Institute of Naples experience. In: Cancer Biology and Therapy. 2010 ; Vol. 10, No. 12. pp. 1240-1243.
@article{4de9e7bcd307495ba4c1ee18e3e80f59,
title = "Metabolic syndrome affects breast-cancer risk in postmenopausal women: National Cancer Institute of Naples experience",
abstract = "Postmenopausal women show the highest incidence of breast cancer in the female population and are often affected by metabolic syndrome. Metabolic syndrome (MS)-characterized by central adiposity, insulin resistance, low serum high-density lipoprotein cholesterol (HDL-C), high serum triglyceride and high blood pressure-seems to be strictly correlated to breast carcinogenesis. We enrolled 777 healthy women and women with breast cancer in our nested casecontrol study to evaluate the association between MS and breast cancer, analyzing anthropometric parameters (weight, height, BMI, waist and hip circumference), blood pressure, serum HDL-C, triglyceride, fasting plasma glucose, insulin, testosterone and uric acid levels and administering a questionnaire about physical activity, food intake, tobacco use, alcohol abuse, personal and familial history of disease. We found an higher prevalence of metabolic syndrome (30{\%}) in postmenopausal breast cancer patients compared to healthy women (19{\%}). None of the individual MS features was strong enough to be considered responsible for breast carcinogenesis alone. However, of the 63 postmenopausal breast cancer cases associated to MS, 30{\%} presented three or more MS features, suggesting that the activation of multiple molecular pathways underlying MS might contribute to tumorigenesis. Our data support the hypothesis that MS may be an indicator of breast cancer risk in postmenopausal women. The unsettlement of the hormonal arrangement in postmenopausal, along with an increase in visceral adiposity, probably favour the hormone-dependent cell proliferation, which drives tumorigenesis. Adjustments in lifestyle with physical activity intensification and healthy diet could represent modifiable factors for the primary prevention of sporadic breast cancer.",
keywords = "Body mass index, Breast cancer, High-density lipoprotein cholesterol (HDL-C), Hyperandrogenic status, Hyperinsulinemia, Insulin resistance, Insulin-like growth factor 1 (IGF-1), Metabolic syndrome, Postmenopausal, Weight gain",
author = "Immacolata Capasso and Emanuela Esposito and Francesca Pentimalli and Anna Crispo and Maurizio Montella and Maria Grimaldi and {De Marco}, Mariarosaria and Ernestina Cavalcanti and Massimiliano D'Aiuto and Alfredo Fucito and Giuseppe Frasci and Nicola Maurea and Giuseppe Esposito and Tonino Pedicini and Aldo Vecchione and Giuseppe D'Aiuto and Antonio Giordano",
year = "2010",
month = "12",
day = "15",
doi = "10.4161/cbt.10.12.13473",
language = "English",
volume = "10",
pages = "1240--1243",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "12",

}

TY - JOUR

T1 - Metabolic syndrome affects breast-cancer risk in postmenopausal women

T2 - National Cancer Institute of Naples experience

AU - Capasso, Immacolata

AU - Esposito, Emanuela

AU - Pentimalli, Francesca

AU - Crispo, Anna

AU - Montella, Maurizio

AU - Grimaldi, Maria

AU - De Marco, Mariarosaria

AU - Cavalcanti, Ernestina

AU - D'Aiuto, Massimiliano

AU - Fucito, Alfredo

AU - Frasci, Giuseppe

AU - Maurea, Nicola

AU - Esposito, Giuseppe

AU - Pedicini, Tonino

AU - Vecchione, Aldo

AU - D'Aiuto, Giuseppe

AU - Giordano, Antonio

PY - 2010/12/15

Y1 - 2010/12/15

N2 - Postmenopausal women show the highest incidence of breast cancer in the female population and are often affected by metabolic syndrome. Metabolic syndrome (MS)-characterized by central adiposity, insulin resistance, low serum high-density lipoprotein cholesterol (HDL-C), high serum triglyceride and high blood pressure-seems to be strictly correlated to breast carcinogenesis. We enrolled 777 healthy women and women with breast cancer in our nested casecontrol study to evaluate the association between MS and breast cancer, analyzing anthropometric parameters (weight, height, BMI, waist and hip circumference), blood pressure, serum HDL-C, triglyceride, fasting plasma glucose, insulin, testosterone and uric acid levels and administering a questionnaire about physical activity, food intake, tobacco use, alcohol abuse, personal and familial history of disease. We found an higher prevalence of metabolic syndrome (30%) in postmenopausal breast cancer patients compared to healthy women (19%). None of the individual MS features was strong enough to be considered responsible for breast carcinogenesis alone. However, of the 63 postmenopausal breast cancer cases associated to MS, 30% presented three or more MS features, suggesting that the activation of multiple molecular pathways underlying MS might contribute to tumorigenesis. Our data support the hypothesis that MS may be an indicator of breast cancer risk in postmenopausal women. The unsettlement of the hormonal arrangement in postmenopausal, along with an increase in visceral adiposity, probably favour the hormone-dependent cell proliferation, which drives tumorigenesis. Adjustments in lifestyle with physical activity intensification and healthy diet could represent modifiable factors for the primary prevention of sporadic breast cancer.

AB - Postmenopausal women show the highest incidence of breast cancer in the female population and are often affected by metabolic syndrome. Metabolic syndrome (MS)-characterized by central adiposity, insulin resistance, low serum high-density lipoprotein cholesterol (HDL-C), high serum triglyceride and high blood pressure-seems to be strictly correlated to breast carcinogenesis. We enrolled 777 healthy women and women with breast cancer in our nested casecontrol study to evaluate the association between MS and breast cancer, analyzing anthropometric parameters (weight, height, BMI, waist and hip circumference), blood pressure, serum HDL-C, triglyceride, fasting plasma glucose, insulin, testosterone and uric acid levels and administering a questionnaire about physical activity, food intake, tobacco use, alcohol abuse, personal and familial history of disease. We found an higher prevalence of metabolic syndrome (30%) in postmenopausal breast cancer patients compared to healthy women (19%). None of the individual MS features was strong enough to be considered responsible for breast carcinogenesis alone. However, of the 63 postmenopausal breast cancer cases associated to MS, 30% presented three or more MS features, suggesting that the activation of multiple molecular pathways underlying MS might contribute to tumorigenesis. Our data support the hypothesis that MS may be an indicator of breast cancer risk in postmenopausal women. The unsettlement of the hormonal arrangement in postmenopausal, along with an increase in visceral adiposity, probably favour the hormone-dependent cell proliferation, which drives tumorigenesis. Adjustments in lifestyle with physical activity intensification and healthy diet could represent modifiable factors for the primary prevention of sporadic breast cancer.

KW - Body mass index

KW - Breast cancer

KW - High-density lipoprotein cholesterol (HDL-C)

KW - Hyperandrogenic status

KW - Hyperinsulinemia

KW - Insulin resistance

KW - Insulin-like growth factor 1 (IGF-1)

KW - Metabolic syndrome

KW - Postmenopausal

KW - Weight gain

UR - http://www.scopus.com/inward/record.url?scp=78650334747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650334747&partnerID=8YFLogxK

U2 - 10.4161/cbt.10.12.13473

DO - 10.4161/cbt.10.12.13473

M3 - Article

C2 - 20935521

AN - SCOPUS:78650334747

VL - 10

SP - 1240

EP - 1243

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 12

ER -